176 related articles for article (PubMed ID: 25027334)
1. Endometrial carcinoma in women 40 year old or younger: a case report and literature review.
Gerli S; Spanò F; Di Renzo GC
Eur Rev Med Pharmacol Sci; 2014; 18(14):1973-8. PubMed ID: 25027334
[TBL] [Abstract][Full Text] [Related]
2. Updates on Conservative Management of Endometrial Cancer.
Corzo C; Barrientos Santillan N; Westin SN; Ramirez PT
J Minim Invasive Gynecol; 2018 Feb; 25(2):308-313. PubMed ID: 28782618
[TBL] [Abstract][Full Text] [Related]
3. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
4. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Corrado G; Baiocco E; Carosi M; Vizza E
Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
[TBL] [Abstract][Full Text] [Related]
5. Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series.
Falcone F; Normanno N; Losito NS; Scognamiglio G; Esposito Abate R; Chicchinelli N; Casella G; Laurelli G; Scaffa C; Greggi S
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():220-225. PubMed ID: 31326637
[TBL] [Abstract][Full Text] [Related]
6. Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schema.
Matsuo K; Mandelbaum RS; Matsuzaki S; Klar M; Roman LD; Wright JD
Am J Obstet Gynecol; 2021 Jun; 224(6):574-584. PubMed ID: 33412129
[TBL] [Abstract][Full Text] [Related]
7. Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Giampaolino P; Cafasso V; Boccia D; Ascione M; Mercorio A; Viciglione F; Palumbo M; Serafino P; Buonfantino C; De Angelis MC; Verrazzo P; Grasso G; Gullo G; Bifulco G; Della Corte L
Biomed Res Int; 2022; 2022():4070368. PubMed ID: 36203482
[TBL] [Abstract][Full Text] [Related]
8. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.
Herrera Cappelletti E; Humann J; Torrejón R; Gambadauro P
Hum Reprod Update; 2022 Feb; 28(2):282-295. PubMed ID: 34935045
[TBL] [Abstract][Full Text] [Related]
9. Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
Yang HC; Liu JC; Liu FS
Taiwan J Obstet Gynecol; 2019 Jan; 58(1):90-93. PubMed ID: 30638488
[TBL] [Abstract][Full Text] [Related]
10. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.
Park JY; Nam JH
Oncologist; 2015 Mar; 20(3):270-8. PubMed ID: 25673106
[TBL] [Abstract][Full Text] [Related]
11. Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.
Uccella S; Zorzato PC; Dababou S; Bosco M; Torella M; Braga A; Frigerio M; Gardella B; Cianci S; Laganà AS; Franchi MP; Garzon S
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143933
[TBL] [Abstract][Full Text] [Related]
12. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
Shan BE; Ren YL; Sun JM; Tu XY; Jiang ZX; Ju XZ; Zang RY; Wang HY
Arch Gynecol Obstet; 2013 Nov; 288(5):1115-23. PubMed ID: 23644919
[TBL] [Abstract][Full Text] [Related]
14. Fertility-Sparing Management Using Progestin for Young Women with Endometrial Cancer From a Population-Based Study.
Kim SR; van der Zanden C; Ikiz H; Kuzelijevic B; Havelock J; Kwon JS
J Obstet Gynaecol Can; 2018 Mar; 40(3):328-333. PubMed ID: 28986185
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of ovarian preservation for stage I endometrial carcinomas in women aged 40 years and younger].
Li L; Wu L; Zhang R; Zhang G; Li N; Li X; Yuan G
Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):260-4. PubMed ID: 24969332
[TBL] [Abstract][Full Text] [Related]
16. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
17. [Endometrial cancer in young patients: report of 17 cases].
Dudnyikova A; Horváth K; Pete I
Magy Onkol; 2013 Sep; 57(3):203-6. PubMed ID: 24107826
[TBL] [Abstract][Full Text] [Related]
18. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
19. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
[TBL] [Abstract][Full Text] [Related]
20. Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature.
Vandenput I; Van Eygen K; Moerman P; Vergote I; Amant F
Eur J Gynaecol Oncol; 2009; 30(3):313-6. PubMed ID: 19697629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
